Ignite Creation Date:
2024-05-06 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03505554
Status:
RECRUITING
Last Update Posted:
2023-08-07
First Post:
2018-04-06
Brief Title:
A Study of Oral Lorlatinib in Patients With Relapsed ALK Positive Lymphoma
Sponsor:
University of Milano Bicocca
Organization:
University of Milano Bicocca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-06
First Submit QC Date:
April 20 2018
Study First Post Date:
2018-04-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-04
Last Update Post Date:
2023-08-07
Last Update Post Date Type:
ACTUAL